These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33336742)

  • 41. MIIP inhibits malignant progression of hepatocellular carcinoma through regulating AKT.
    Fang J; Chen YL; Yao HB; Peng SS; Yang P; Ding ZY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2335-2346. PubMed ID: 32196585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-130-5p promotes invasion as well as migration of lung adenocarcinoma cells by targeting the EZH2 signaling pathway.
    Zhang G; Wu YJ; Yan F
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9480-9488. PubMed ID: 31773700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-326 inhibits cell proliferative capacity and invasiveness through inhibiting the expression of ETS1 in nasopharyngeal carcinoma.
    Zhao X; Zhang XJ; Li L; Xia ST; Cheng L
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):181-188. PubMed ID: 31957831
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LncRNA HOTAIR promotes colon cancer development by down-regulating miRNA-34a.
    Peng CL; Zhao XJ; Wei CC; Wu JW
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5752-5761. PubMed ID: 31298326
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
    Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-424-5p inhibits the development of non-small cell LCa by binding to ITGB1.
    Xu ZL; Zhang M; Chen SX; Qiu M; Zhang Q; Gao LP; Li JDX
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8921-8930. PubMed ID: 31696479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.
    Wang Y; Liu BG; Zhou CX
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LINC00261 regulates EBF1 to suppress malignant progression of thyroid cancer.
    Fu XD; Liu CY; Liu YL; Su DW; Chi NN; Zhang JL; Wei WW
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7626-7634. PubMed ID: 34982424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
    Xu L; Hou TJ; Yang P
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-196b promotes cell growth and metastasis of ovarian cancer by targeting ZMYND11.
    Zhang Z; Xu L; Hu Z; Yang B; Xu J
    Minerva Med; 2022 Aug; 113(4):707-717. PubMed ID: 32512976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LINC01857 promotes the development of gastric cancer by regulating microRNA-200b.
    Chen GR; Sun W; Zheng K; Zhu W
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3648-3656. PubMed ID: 32329840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
    Meng XF; Zhao LY; Chu XF
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LncRNA LACAT1 promotes proliferation of oral squamous cell carcinoma cells by inhibiting microRNA-4301.
    Wang J; Huo F; Wang XR; Xu YY
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2427-2435. PubMed ID: 30964168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. microRNA-216a-5p inhibits the development of gastric cancer through target combination with TCTN1.
    Xu X; Gao F; Wang J; Long C; Tao L; Ding L; Ji Y
    Minerva Med; 2023 Jun; 114(3):323-331. PubMed ID: 32486612
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MiRNA-199 inhibits malignant progression of lung cancer through mediating RGS17.
    Su WZ; Ren LF
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3390-3400. PubMed ID: 31081094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclic RNA hsa_circ_0091017 inhibits proliferation, migration and invasiveness of bladder cancer cells by binding to microRNA-589-5p.
    Zhang L; Xia HB; Zhao CY; Shi L; Ren XL
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):86-96. PubMed ID: 31957821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. USP3 promotes proliferation of non-small cell lung cancer through regulating RBM4.
    Liao XH; Wang Y; Zhong B; Zhu SY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3143-3151. PubMed ID: 32271432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
    Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
    Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Golgi phosphoprotein-3 (GOLPH3) promote metastasis of nasopharyngeal carcinoma through regulating E-cadherin.
    Wang DY; Wang J; Deng D
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8871-8879. PubMed ID: 32964976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EphA3 promotes the proliferation of NPC cells through negatively regulating the ability of FOG2.
    Song Z; Gao S; Liu YM; Wang Y; Sun ZX; Bao D; Liu C
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6735-6743. PubMed ID: 32633364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.